Lilly’s Retatrutide Outperforms Ozempic on Weight Loss and Blood Sugar Control in Phase 2 Trial
Phase 2 trial results showed Lilly’s retatrutide outperformed Ozempic on weight loss and blood sugar control.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.
News Feed
3 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
Lilly’s Retatrutide Outperforms Ozempic in Weight Loss and Blood Sugar Control in Clinical Trial
A clinical trial found retatrutide outperformed Ozempic on weight loss and blood sugar control; the report provides no further trial details.
Lilly's Retatrutide Outperforms Ozempic on Weight Loss and Blood Sugar Control in Trial
A trial found Lilly's retatrutide outperformed Ozempic on weight loss and blood sugar control.